Edesa Biotech Announces Proposed Public Offering

TORONTO, Aug. 19, 2026 (GLOBE NEWSWIRE) — Edesa Biotech, Inc. (Nasdaq: EDSA) (the “Company” or “Edesa”), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today announced that it has commenced an underwritten public offering of its common shares (or pre-funded warrants to purchase common shares in lieu thereof) and…

financialpost.com ·2026-08-19

We haven't written up this one. Financial Post has the full story — the link below goes straight to it.

Read the original at financialpost.com →

More in Finance & Markets

Bessent moves to curb Treasury yields, putting new pressure on Warsh's Fed

Treasury's move to buy back more long-term debt cooled a bond selloff, but economists warn it could raise new inflation and independence questions for the Fed

2026-08-19 ·cnbc.com

Why High Yields on Government Bonds Are Causing Alarm

Government borrowing costs have been surging around the world as investors demand more compensation to entice them to hold longer-maturity debt.

2026-08-19 ·bloomberg.com

Estée Lauder CEO Says Company Has 'Great Momentum'

Estée Lauder Cos. Chief Executive Officer Stéphane de La Faverie says the company is expanding margin and has great momentum going forward. The beauty and makeup giant reported revenue and earnings for the fiscal fourth quarter that topped estimates. He speaks on "Bloomberg The Close." (Source: Bloomberg)

2026-08-19 ·bloomberg.com

Edesa Biotech Announces Proposed Public Offering

More in Finance & Markets

Ethereum Climbs 10% In Rally

Mortgage rates dip, remain near one-year high

$100 Diesel Cracks Signal a Much Tighter Oil Market Than Brent Suggests

Bessent moves to curb Treasury yields, putting new pressure on Warsh's Fed

Why High Yields on Government Bonds Are Causing Alarm

Estée Lauder CEO Says Company Has 'Great Momentum'